Enovis (ENOV)
(Delayed Data from NYSE)
$45.40 USD
-1.14 (-2.45%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $45.43 +0.03 (0.07%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth D Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ENOV 45.40 -1.14(-2.45%)
Will ENOV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ENOV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ENOV
Standard BioTools (LAB) Reports Q2 Loss, Misses Revenue Estimates
Analysts Estimate Enovis (ENOV) to Report a Decline in Earnings: What to Look Out for
ENOV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should You Buy Hims & Hers (HIMS) Stock Ahead of Q2 Earnings?
Select Medical's (SEM) Unit Begins IPO Roadshow for 22.5M Shares
Zacks.com featured highlights include Energizer, Super League Enterprise and Enovis
Other News for ENOV
Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
Enovis to Host Second Quarter 2024 Results Conference Call on August 7th
Enovis? Releases AltiVate Reverse? Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse?
Top 3 Health Care Stocks That Could Blast Off In June
August 16th Options Now Available For Enovis (ENOV)